The HPV vaccine not only protects against cervical cancer but can also significantly reduce the risk of various HPV-related cancers in men. Experts therefore now recommend the vaccine for both girls and boys.
Human papillomaviruses (HPV) are among the most common sexually transmitted viruses. While HPV is often associated with cervical cancer, these viruses can also cause serious diseases in men. These include certain types of cancer in the oropharyngeal region, anal cancer, and penile cancer. In addition, HPV infections can lead to genital warts.
The HPV vaccine protects against the most common cancer-causing types of HPV and significantly reduces the risk of HPV-related diseases.
When should the vaccine be administered?
The Federal Office of Public Health (FOPH) recommends the HPV vaccine for all adolescents aged 11 to 14. At this age, two doses of the vaccine are sufficient. For adolescents and young adults between the ages of 15 and 26, a catch-up or supplemental vaccination series consisting of three doses is recommended.
As a general rule, the earlier the vaccination, the better. Ideally, it should be administered before a person becomes sexually active.
Coverage up to age 26
As part of the cantonal vaccination programs, the HPV vaccine is covered by basic health insurance for people between the ages of 11 and 26. Men should therefore actively bring up the topic with their family doctor or the healthcare professional treating them.
Getting an HPV vaccine can still be beneficial even after the age of 26. However, in this case, the costs are generally no longer covered by basic health insurance.
Effective Measures for Cancer Prevention
The HPV vaccine is an effective measure for cancer prevention and makes an important contribution to men’s health. It protects against various HPV-related diseases and is now explicitly recommended for boys and men as well.
